Background Human papillomavirus (HPV) infection can have severe consequences both in
women and men. Preadolescent girls are vaccinated against HPV worldwide but a gender …

Objectives Economic evaluations of vaccines should accurately represent all relevant
economic and health consequences of vaccination, including losses due to adverse events …

Summary Background In Australia, the government-funded human papillomavirus (HPV)
vaccination programme was introduced in April, 2007, for girls and young women, and in …

Our aim was to conduct a large epidemiologic analysis of the distribution of human
papilloma virus (HPV) genotypes associated with cervical neoplasias and cancers at a …

Introduction Vaccination against human papillomavirus (HPV) is considered the most
effective strategy to protect women from cervical cancer. Three HPV vaccines are currently …

Background A bivalent human papillomavirus vaccine (2vHPV) is currently used in the
Netherlands; a nonavalent vaccine (9vHPV) is also licensed. Research design and methods …

Of the 604,127 cases and 341,831 deaths attributable to cervical cancer in 2020, China
accounted for an estimated 109,741 (18%) cases and 59,060 (17%) deaths. 1 Human …

ABSTRACT In 2020, there were approximately 50,865 anal cancer cases and 36,068 penile
cancer cases worldwide. HPV is considered the main causal agent for the development of …

Background/purpose The incidence of human papillomavirus (HPV)-related oropharyngeal
cancer (OPC) is increasing worldwide. HPV vaccines have shown efficacy in preventing …

Abstract In the Netherlands, the Health Council has advised that the human papillomavirus
(HPV) vaccination should be offered to both boys and girls. Additionally, boys and men up to …